Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
Pigment Cell & Melanoma Research|June 24, 2026
Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Andrew E Aplin, Katherina Alsina, Allison S Betof, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II ConsortiumStephanie Lheureux, Anna Tinker, Blaise Clarke, et al.Journal for Immunotherapy of Cancer|June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancerMary L Disis, Sarah F Adams, Jyoti Bajpai, et al.Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.Journal of Experimental & Clinical Cancer Research : CR|October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.Frontiers in Oncology|June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical TrialsRamy Gadalla, Babak Noamani, Bethany L MacLeod, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2023
Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoireDouglas G Millar, S Y Cindy Yang, Azin Sayad, et al.Nature Medicine|October 13, 2022
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trialRichard D Carvajal, Marcus O Butler, Alexander N Shoushtari, et al.Nature Communications|February 6, 2024
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patientScott C Lien, Dalam Ly, S Y Cindy Yang, et al.Pageof 16